Skip to main content
Log in

Camrelizumab/tislelizumab

Reactive cutaneous capillary endothelial proliferation and drug-induced erythema multiforme

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Hui H-Z, et al. Camrelizumab-induced reactive cutaneous capillary endothelial proliferation followed by tislelizumab-induced erythema multiforme in a patient with acute myeloid leukemia. International Journal of Dermatology 63: 251-253, No. 2, Feb 2024. Available from: URL: https://dx.doi.org/10.1111/ijd.16945

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Camrelizumab/tislelizumab. Reactions Weekly 1995, 48 (2024). https://doi.org/10.1007/s40278-024-53311-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-024-53311-x

Navigation